Synthes** Net Worth is7.8 12-Month Sales Growth (%)
VN:F [1.9.22_1171]
deserves the money?
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.22_1171]
Would you date ?
Rating: 0.0/5 (0 votes cast)
Company Name: Synthes Holding AG

Company Logo: Image:Synthes.svg

Company Type: Aktiengesellschaft

Traded As: SYST

Foundation: 1999

Location: Solothurn, Switzerland (corporate), West Chester, Pennsylvania, Pennsylvania, United States (operational)

Key People: Hansjörg Wyss (Chairman), Michel Orsinger (President and chief executive officer)

Industry: Health care

Products: Physical trauma, Vertebral column, Craniofacial surgery, human mandible and chest Implant (medicine), medical power tools, biomaterials

Revenue: United States dollar3.687 billion (2010)
Operating Income: US $1.283 billion (2010)
Net Income: US $907.7 million (2010)
Assets: US $7.924 billion (end 2010)
Equity: US $6.739 billion (end 2010)
Num Employees: 11,430 (end 2010)
Homepage: [http://www.synthes.com www.synthes.com]

Intl: yes

Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures, and also produces surgical power tools and advanced biomaterials. Synthes is controlled by chairman, former CEO and largest shareholder HansjA?rg Wyss, who is ranked 121st on the 2010 Forbes list of richest people in the world. The company's shares are listed on the SIX Swiss Exchange and the firm is a constituent of the SMI index.
Synthes was originally established in 1960 as a trademark of the non-profit institute Arbeitsgemeinschaft fA 1/4 r Osteosynthesefragen (English: Association for the Study of Internal Fixation, AO/ASIF), which was applied to internal fixation implants produced under licence by its industrial partners, Straumann Group and Mathys Medizinaltechnik. In 1975 Synthes USA, a firm founded by Harvard graduate HansjA?rg Wyss, became the third company to form an alliance with AO/ASIF, while Straumann and Mathys expanded their coverage around the rest of the world throughout the decade.
In 1990 Straumann spun off its implant business into a separate privately owned company, Stratec Medical. Stratec partially listed its shares on the SWX Swiss Exchange through an initial public offering six years later, while Synthes USA and Mathys remained in private hands. Three years later, however, Stratec and Synthes USA merged to form a new publicly-traded company named Synthes-Stratec. After the merger HansjA?rg Wyss became, and remains today, the majority shareholder of the enlarged company. The third of the original AO/ASIF partner companies, Mathys, sold its osteosynthesis department to Synthes-Stratec in 2004, although the firm's German division was divested to satisfy competition authorities. The company subsequently dropped the "-Stratec" suffix to become simply Synthes. The company's shares were added to the bench

Synthes** Latest News

DePuy Synthes, Wright Medical Lead US Market for Orthopedic Small Bone and Joint Devices Due to Increased Foot & Ankle Procedures

Overall, the U.S. small bone and joint orthopedic devices market is expected to increase over the next several years to reach an estimated $4 billion by 2023 Vancouver, BC -- (ReleaseWire) -- 08/18/2017 --According to a new series of reports on the U.S ...
Posted: August 18, 2017, 12:55 pm

J&J’s DePuy Synthes inks co-marketing deal with Medical Enterprises Distribution

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked an exclusive agreement with Medical Enterprises Distribution to co-market its ME1000 surgical impactor, designed for use in total hip arthroplasty procedures. The battery-powered ...
Posted: August 7, 2017, 12:05 pm

Global Orthopaedic Devices Market 2017-2023 - Prominent Players Include Zimmer Biomet, DePuy Synthes, Stryker, Medtronic, and Smith & Nephew

The "Global Orthopaedic Devices Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering. The Orthopedic Devices Market revenue in APAC is expected to reach $11.72 billion by 2023, growing ...
Posted: August 8, 2017, 1:48 pm

BRIEF-DePuy Synthes collaborates with Medical Enterprises Distribution to co-market ME1000

* DePuy Synthes says exclusive agreement with Medical Enterprises Distribution to co-market ME1000 surgical impactor for use in Total Hip Arthroplasty * DePuy Synthes - is expected to begin co-marketing ME1000 with Medical Enterprises Distribution LLC ...
Posted: August 7, 2017, 7:05 am

DePuy Synthes Elbow Replacement Litigation

DePuy Synthes faces potential lawsuits after it announced a global product removal of more than 50,000 elbow implants in December 2016. The company warned that the stem of its Radial Head Prosthesis System could loosen, leading to potential medical ...
Posted: August 18, 2017, 1:58 pm
Related Topics:
How Much Is Synthes** Earnings, How Much Is Synthes** Income, How Much Is Synthes** Net Worth, How Much Is Synthes** Salary, How Much Is Synthes** Worth, Synthes Cafepharma, Synthes Depuy, Synthes E Catalog, Synthes Ecatalog, Synthes Help, Synthes Inc, Synthes Investor Relations, Synthes Katalog, Synthes Know Your Options, Synthes Medical, Synthes Nail Recall, Synthes North America, Synthes Orthopedics, Synthes Products, Synthes Resident, Synthes Resident Book Program, Synthes Resident Program, Synthes Resident Us, Synthes Spine, Synthes Technique Guides, Synthes Trauma, Synthes Usa, Synthes Wiki, Synthes**, Synthes** Age, Synthes** Bio, Synthes** Country, Synthes** Date Of Birth, Synthes** Earnings, Synthes** Ethnicity, Synthes** Gossips, Synthes** Height, Synthes** History, Synthes** Home Town, Synthes** Images, Synthes** Income, Synthes** Job, Synthes** Nationality, Synthes** Net Worth, Synthes** Networth, Synthes** News, Synthes** Partner, Synthes** Place Of Birth, Synthes** Rumors, Synthes** Salary, Synthes** Secrets, Synthes** Videos, Synthes** Weight, Synthese Wiki, Synthesis Resident Program, Who Is Synthes**,